Literature DB >> 20629123

Neuronal intranuclear inclusion disease: two cases of dopa-responsive juvenile parkinsonism with drug-induced dyskinesia.

Szu-Chia Lai1, Shih-Ming Jung, Padraic Grattan-Smith, Ella Sugo, Yen-Wen Lin, Rou-Shayn Chen, Chiung-Chu Chen, Yah-Huei Wu-Chou, Anthony E Lang, Chin-Song Lu.   

Abstract

There are very few conditions that present with dopa-responsive juvenile parkinsonism. We present two such children with neuronal intranuclear inclusion disease (NIID) who had an initial good levodopa response that was soon complicated by disabling dopa-induced dyskinesia. One child was diagnosed by rectal biopsy in life, and the other diagnosis was confirmed at postmortem. In this patient, dopamine transporter imaging showed severely decreased binding of the radiotracer in the striatum on both sides. Bilateral subthalamic deep brain stimulation in this patient produced initial improvement, but this was not sustained. Both patients died within 10 years of symptom onset. As well as levodopa responsiveness with rapid onset of dyskinesia, clues to the diagnosis of NIID in patients presenting with parkinsonism include the presence of gaze-evoked nystagmus, early onset dysarthria and dysphagia and oculogyric crises. Differential diagnosis of clinical symptoms and neuropathological findings are discussed including the approach to rectal biopsy for early diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20629123     DOI: 10.1002/mds.22876

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 2.  Juvenile Huntington's Disease: Diagnostic and Treatment Considerations for the Psychiatrist.

Authors:  Joanna Quigley
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

3.  Neuronal Intranuclear Inclusion Disease: Longitudinal Case Report of Motor and Nonmotor Symptoms.

Authors:  Jennifer Vermilion; Mahlon Johnson; Jayasri Srinivasan; Jonathan W Mink
Journal:  J Child Neurol       Date:  2019-07-15       Impact factor: 1.987

Review 4.  Clinical and mechanism advances of neuronal intranuclear inclusion disease.

Authors:  Yueqi Liu; Hao Li; Xuan Liu; Bin Wang; Hao Yang; Bo Wan; Miao Sun; Xingshun Xu
Journal:  Front Aging Neurosci       Date:  2022-09-13       Impact factor: 5.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.